Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Geron Corporation    GERN   US3741631036

GERON CORPORATION (GERN)

19
Delayed Quote. Delayed Nasdaq - 12/19 04:00:06 pm
3.26 USD   -0.31%
3d ago GERON : reports 3Q loss
4d ago GERON : Announces Early HSR Clearance for Global Strategic Collabora..
12/05 GERON : to Host Analyst and Investor Meeting on December 8
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/15/2014 12/16/2014 12/17/2014 12/18/2014 12/19/2014 Date
2.98(c) 3.04(c) 3.15(c) 3.27(c) 3.26(c) Last
4 622 890 3 163 738 2 532 181 3 065 779 7 242 660 Volume
-8.02% +2.01% +3.62% +3.81% -0.31% Change
More quotes
Company
Geron Corp. discovers and develops therapeutic products for cancer.It is a clinical stage biopharmaceutical company developing a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.The company's imetelstat, their sole product candidate, is a potent and specific inhibitor of... 
More about the company
Surperformance© ratings of Geron Corporation
Trading Rating : Investor Rating :
More Ratings
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 24,6 M
EBIT 2014 -13,6 M
Net income 2014 -12,9 M
Debt 2014 -
Yield 2014 -
Sales 2015 1,38 M
EBIT 2015 -43,6 M
Net income 2015 -43,5 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 20,8x
Capi. / Sales 2015 371x
Capitalization 513 M
More Financials
Latest news on GERON CORPORATION
3d ago GERON : reports 3Q loss
4d ago GERON : Other Events, Financial Statements and Exhibits (form 8-K)
4d ago GERON : Announces Early HSR Clearance for Global Strategic Collaboration with Ja..
12/05 GERON : to Host Analyst and Investor Meeting on December 8
12/04 GERON : Announces Publication of Preclinical Data on Imetelstat Activity in Acut..
11/26 GERON : to Present at the 26th Annual Piper Jaffray Healthcare Conference
11/18 GERON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
11/14 GERON : to Present at the Stifel Healthcare Conference
More news
Sector news
1d ago ISIS PHARMACEUTICALS : IWM, HEZU: Big ETF Inflows
1d ago PUMA BIOTECHNOLOGY : SHAREHOLDER ALERT: Investigation on Behalf of Investors of ..
1d ago ALNYLAM PHARMACEUTICALS : Announces Planned Departure of Chief Business Officer,..
More sector news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF